ABPA (Allergic Bronchopulmonary Aspergillosis) Hub

ABPA is an allergic reaction in the lungs caused by the immune system over-responding to Aspergillus fungus.

This hub brings together the key topics that patients ask about most often, including IgE, eosinophils, mucus plugging, flare-ups, steroids and biologics.

Topics in This Hub

Latest ABPA Articles

Illustration of a T cell recognising a fungal antigen and coordinating an immune response near Aspergillus fumigatus.

Is a vaccine for chronic pulmonary aspergillosis (CPA) being developed?

August 18, 2026

Medical illustration of lung bullae and a clinician reviewing a chest CT scan for Aspergillus-related changes.

Pneumothorax, Bullae and Aspergillosis: Why Old Lung Damage Can Matter

August 12, 2026

Illustration of cystic fibrosis airways with thick mucus and a sputum sample being assessed for Aspergillus.

Cystic Fibrosis and Aspergillus: When Does It Matter?

August 12, 2026

Doctor reviewing spirometry, CT imaging and lung diagrams to assess COPD, bronchiectasis and overlapping lung disease

COPD, Bronchiectasis and Aspergillosis: Understanding Overlapping Lung Conditions

August 10, 2026

CT-style illustration showing widened bronchiectatic airways, mucus plugging and an aspergilloma

Bronchiectasis and Aspergillosis: Understanding the Connection

August 10, 2026

Medical illustration showing narrowed mucus-filled airways, emphysema and an Aspergillus fungal ball in COPD

COPD and Aspergillosis: Understanding the Connection

August 10, 2026

Medical illustration showing nasal polyps, inflamed lungs and dupilumab targeting inflammation throughout the connected airway

Could One Biologic Treat Nasal Polyps, Asthma and ABPA?

August 5, 2026

Illustration of lungs, airway cells, DNA and Aspergillus spores representing Manchester research into genetic susceptibility to aspergillosis.

Can We Predict Who Will Develop Aspergillosis? Genetics, Epigenetics and the Search for Individual Risk

August 4, 2026

Illustration of lungs, a DNA strand and Aspergillus spores representing research into CFTR gene variants and ABPA

Carriers of cystic fibrosis may be at greater risk for allergic bronchopulmonary aspergillosis

July 20, 2026

Patient with Allergic Bronchopulmonary Aspergillosis (ABPA) considering biologic treatment, alongside an infographic explaining why steroids and antifungal medicines are often used before biologics.

Why Do People With ABPA Usually Have to Try Steroids and Antifungals Before Biologics?

June 1, 2026

Medical infographic explaining Primary Ciliary Dyskinesia (PCD), symptoms, mucus clearance problems, fertility effects, diagnosis and possible links with ABPA and bronchiectasis.

Primary Ciliary Dyskinesia (PCD), Fertility and Aspergillosis

May 20, 2026

Infographic explaining adrenal suppression, cortisol, ACTH, steroid side effects and antifungal interactions in patients with ABPA and aspergillosis.

Understanding Steroids, Cortisol, ACTH and Adrenal Suppression in Aspergillosis

May 18, 2026

Person with chronic lung disease experiencing severe breathlessness despite normal oxygen saturation readings, alongside breathing retraining and respiratory health information

When Breathlessness Feels Severe — Even When Oxygen Levels Look “Normal”

May 12, 2026

Infographic showing causes of weight loss and weakness in aspergillosis including inflammation, reduced appetite, medication effects and muscle loss, with stages of recovery.

Weight Loss and Weakness in Aspergillosis: Why It Happens, How It Feels, and What Helps Recovery

April 28, 2026

Diagram showing why aspergillosis is often controlled rather than cured, including differences between ABPA and chronic pulmonary aspergillosis (CPA)

Can Aspergillosis Be Cured? Understanding Treatment, Control, and Long-Term Therapy

April 27, 2026

Infographic showing ABPA cycle: Aspergillus spores, airway colonisation, immune reaction, inflammation and treatments including steroids and antifungals

ABPA: Allergic Reaction or Fungal Presence in the Lungs?

April 22, 2026

Cystic Fibrosis, CFTR Gene Variants, and Aspergillosis

April 8, 2026

Asthma and Aspergillosis

March 9, 2026

Looking further into the future – could we control lung damage, preserve healthy lung tissue better?

February 13, 2026

🧬 How Biologics Are Reshaping Our Understanding of ABPA Subtypes

February 13, 2026

🧬 Could Antibody-Driven Dissolving of Charcot–Leyden Crystals Help ABPA?

February 13, 2026

🔬 Charcot–Leyden Crystals in ABPA and Asthma

February 13, 2026

Invitation: Patient & Carer Discussion on Living with ABPA. New type of treatment.

February 10, 2026

Airways mucus and aspergillosis

January 27, 2026

Hyper-IgE syndrome

January 20, 2026

Sinusitis in Patients with ABPA

January 16, 2026

ABPA and Work: What a Patient Poll Tells Us About Employment, Health, and Real-World Impact

January 16, 2026

Why do some people cough up long, tube-shaped pieces of mucus?

December 5, 2025

⭐ Allergic Bronchopulmonary Aspergillosis (ABPA): Why Diagnosis Is Missed and Who Needs to Be More Aware

December 3, 2025

🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know

November 25, 2025

Understanding Mucous Casts in Allergic Bronchopulmonary Aspergillosis (ABPA)

November 20, 2025

🌿 ABPA: Infection, Allergy, Biologics, and What It All Means for You

November 18, 2025

Inhaled Steroids and ABPA: Do They Help or Should They Be Avoided?

November 17, 2025

ABPA or Bronchiectasis? A Detailed Guide to Understanding Flare-Ups

November 17, 2025

🌲 Why Rough-Cut Wood Arrives Mouldy — and How to Reduce the Risk (Important for Aspergillosis Patients)

November 14, 2025

Why Exposure to Young Children Can Increase Illness in Aspergillosis, ABPA, and Bronchiectasis — and How to Track Viral Outbreaks

November 13, 2025

Related Hubs

Did this page help you?

Tell us in one minute